Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | KARS1 | Q15046 | 1/20 | 0.31 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28350743 | 0.86 | CYP1A2 (0.47) | CYP1A2KDM4E | |
| SCHEMBL20772142 | 0.85 | KDM4E (0.44) | CYP1A2KDM4EALDH1A1TDP1 | |
| SCHEMBL7976411 | 0.78 | CYP1A2 (0.46) | CYP1A2KDM4EALDH1A1TDP1 | |
| SCHEMBL10086067 | 0.76 | TSHR (0.39) | — | |
| SCHEMBL28748031 | 0.75 | CYP1A2 (0.37) | CYP1A2KDM4E | |
| SCHEMBL31284806 | 0.75 | CYP1A2 (0.50) | CYP1A2KDM4EALDH1A1TDP1POLB | |
| Hydrochloric Acid SCHEMBL31284551 | 0.74 | CYP1A2 (0.49) | CYP1A2KDM4EALDH1A1TDP1POLB | |
| SCHEMBL7450992 | 0.74 | CYP1A2 (0.57) | CYP1A2KDM4EALDH1A1TDP1POLB | |
| SCHEMBL114682 | 0.74 | CYP1A2 (0.49) | CYP1A2 | |
| SCHEMBL5435198 | 0.74 | CYP1A2 (0.49) | CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2276356-A1 | WARMING SENSATE COMPOSITION | Firmenich S.A. (CH) | 2011-01-26 | — | — | EP | claimed |
| WO-2009127992-A1 | WARMING SENSATE COMPOSITION | FIRMENICH SA (CH) | 2009-10-22 | — | — | WO | claimed |
| EP-4149280-A1 | ROBUST FLAVOR EMULSIONS | International Flavors & Fragrances Inc. (US) | 2023-03-22 | — | — | EP | disclosed |
| WO-2021231886-A1 | ROBUST FLAVOR EMULSIONS | INTERNATIONAL FLAVORS & FRAGRANCES, INC. (US) | 2021-11-18 | — | — | WO | disclosed |
| US-20080008660-A1 | Antimicrobially active compounds for treating bad breath | SYMRISE GMBH & CO. KG (DE) | 2008-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080008660-A1 | Antimicrobially active compounds for treating bad breath | CAT, LPO, GPX1 | CYP1A2 766/4885KDM4E 3726/4885ALDH1A1 555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.